AI predicts response to antipsychotic drugs, could distinguish between disorders

Lawson Health Research Institute, Mind Research Network and Brainnetome Center researchers have developed an algorithm that analyzes brain scans to classify illness in patients with complex mood disorders and help predict their response to medication.

A recent studyanalyzed and compared fMRI scans of those with MDD, bipolar I,  and no history of mental illness, and found that each group’s brain networks differed, including regions in the default mode network and thalamus.

When tested against participants with a known MDD or Bipolar I diagnosis, the algorithm correctly classified illness with 92.4 per cent accuracy.

The team also imaged the brains of 12 complex mood disorder patients with out a clear diagnosis, to predict diagnosis and examine medication response.

The researchers hypothesized that participants classified by the algorithm as having MDDwould respond to antidepressants while those classified as having bipolar I would respond to mood stabilizers. When tested with the complex patients, 11 out of 12 responded to the medication predicted by the algorithm.

According to lead researcher Elizabeth Osuch:: “This study takes a major step towards finding a biomarker of medication response in emerging adults with complex mood disorders. It also suggests that we may one day have an objective measure of psychiatric illness through brain imaging that would make diagnosis faster, more effective and more consistent across health care providers.”

Share: Pinterest